MedTrace Logo

Evoke Radiofrequency Device for Improvement of Skin Appearance

NCT04050033 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-01-11

No results posted yet for this study

Summary

The aim of the study is to evaluate the safety, efficacy, patient comfort and patient satisfaction after Evoke treatment

Conditions

  • Improvement of Skin Appearance

Interventions

DEVICE

Evoke Device

Subjects will undergo treatment with Evoke Device

Sponsors & Collaborators

  • InMode MD Ltd.

    lead INDUSTRY

Principal Investigators

  • Erez Dayan, MD · Avance Plastic Surgery Institute 5570 Longley Lane, Suite A Reno, NV 89511

  • Christopher Chia, MD · BodySculpt 128 Central Park S New York, NY 10019

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-19
Primary Completion
2021-12-30
Completion
2021-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04050033 on ClinicalTrials.gov